The Brain Innovation Days bring the brain ecosystem together to foster dialogue, exchange knowledge, accelerate investment in research & innovation and facilitate business development. This year’s Brain Innovation Days event, to be held on 11-12 October 2022 in Brussels, will centre around “Connecting Brains”; bringing together the current and future generations of brain research and innovation. Abstract submission [...]
Neuroscientist, outstanding science communicator, advocate of animal rights, rationality and openness. The Observer described Blakemore as one of the UK's most influential scientists and a determined and courageous opponent of the violence of the animal rights movement. Colin, despite threats to himself and his family, including a parcel bomb opened by his children [...]
EBC was pleased to be back to another in-person congress last week, attending the FENS Forum on 9-13 July in Paris, France. EBC had a series of events throughout the five days, including a permanent stand in the Exhibition Hall, which brought a lot of interest and saw many EBC materials and giveaways distributed to [...]
The Psychedelic Access and Research European Alliance – PAREA was officially launched today at a virtual event. Keynote Address was delivered by Dr Thomas Insel, former Director of the US National Institute of Mental Health (2002 – 2015). Other speakers included representatives from the European Parliament, European Commission, European Medicines Agency, patients and organizations representing [...]
Brain Talks is a podcast produced by the Brain Innovation Days — a key EBC project — featuring key opinion leaders and stakeholders from the ever-growing brain ecosystem, discussing the latest breakthroughs, ongoing research and other exciting topics related to brain innovation. The first season was launched in 2021, with brilliant speakers from the [...]
On the occasion of Migraine & Headache Awareness Month, the European Brain Council launches "Migraine, my brain" campaign to highlight the need to rethink migraine care. The campaign falls under "RETHINKING Migraine in times of COVID-19", a research-driven project offering tangible policy changes to improve the lives of people living with migraine across Europe. [...]
Registration is now open for two major EBC events in October 2022: the Final Conference of the European Brain Research Area (EBRA) and the Brain Innovation Days, taking place on 11-12 October in Brussels. The 11th will kick off with the three-hour, policy-focused EBRA Final Conference, where key outcomes of the project will be [...]
Supporting the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders The members of the OneNeurology partnership celebrate a major milestone for all those affected by neurological disorders today, with the adoption of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, announced at last week’s 75th World Health Assembly. We fully [...]
We are delighted to share with you the EBC Annual Report for 2021. Despite the ongoing COVID-19 pandemic, we are pleased to have managed to continue to successfully conduct and pursue ongoing projects such as: the Value of Innovation (from which stemmed the development of the EBC Policy Roadmap), MULTI-ACT and the European Brain [...]
Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with [...]
